Literature DB >> 31504625

Cooperative action of APJ and α1A-adrenergic receptor in vascular smooth muscle cells induces vasoconstriction.

Katsumasa Nagano1, Chulwon Kwon2, Junji Ishida1, Tatsuo Hashimoto1,3, Jun-Dal Kim1, Nana Kishikawa4, Mei Murao5, Kenjiro Kimura6, Yoshitoshi Kasuya7, Sadao Kimura7, Yi-Ching Chen8, Hirotsugu Tsuchimochi9, Mikiyasu Shirai9, James T Pearson8,9, Akiyoshi Fukamizu1,10.   

Abstract

The apelin receptor (APJ), a receptor for apelin and elabela/apela, induces vasodilation and vasoconstriction in blood vessels. However, the prolonged effects of increased APJ-mediated signalling, involving vasoconstriction, in smooth muscle cells have not been fully characterized. Here, we investigated the vasoactive effects of APJ gain of function under the control of the smooth muscle actin (SMA) gene promoter in mice. Transgenic overexpression of APJ (SMA-APJ) conferred sensitivity to blood pressure and vascular contraction induced by apelin administration in vivo. Interestingly, ex vivo experiments showed that apelin markedly increased the vasoconstriction of isolated aorta induced by noradrenaline (NA), an agonist for α- and β-adrenergic receptors, or phenylephrine, a specific agonist for α1-adrenergic receptor (α1-AR). In addition, intracellular calcium influx was augmented by apelin with NA in HEK293T cells expressing APJ and α1A-AR. To examine the cooperative action of APJ and α1A-AR in the regulation of vasoconstriction, we developed α1A-AR deficient mice using a genome-editing technique, and then established SMA-APJ/α1A-AR-KO mice. In the latter mouse line, aortic vasoconstriction induced by a specific agonist for α1A-AR, A-61603, were significantly less than in SMA-APJ mice. These results suggest that the APJ-enhanced response requires α1A-AR to contract vessels coordinately.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  APJ; GPCRs; apelin; vasoconstriction; α1A-AR

Mesh:

Substances:

Year:  2019        PMID: 31504625     DOI: 10.1093/jb/mvz071

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  5 in total

1.  Elabela: A Novel Biomarker for Right Ventricular Pressure Overload in Children With Pulmonary Stenosis or Pulmonary Atresia With Intact Ventricular Septum.

Authors:  Jian Wang; Yue Zhou; Qingjie Wang; Bowen Du; Yurong Wu; Qian Chen; Xi Zhang; Yanan Lu; Sun Chen; Kun Sun
Journal:  Front Cardiovasc Med       Date:  2020-11-12

Review 2.  Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis.

Authors:  Emilio Nuñez-Borque; Sergio Fernandez-Bravo; Alma Yuste-Montalvo; Vanesa Esteban
Journal:  Front Immunol       Date:  2022-03-08       Impact factor: 7.561

Review 3.  The beneficial roles of apelin-13/APJ system in cerebral ischemia: Pathogenesis and therapeutic strategies.

Authors:  Jiabin Li; Zhang Chen; Jingyu Chen; Yue Yu
Journal:  Front Pharmacol       Date:  2022-08-10       Impact factor: 5.988

4.  Apelin Does Not Impair Coronary Artery Relaxation Mediated by Nitric Oxide-Induced Activation of BKCa Channels.

Authors:  Amreen Mughal; Chengwen Sun; Stephen T O'Rourke
Journal:  Front Pharmacol       Date:  2021-05-28       Impact factor: 5.810

5.  Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer's Disease.

Authors:  Miles Frost; Abby Keable; Dan Baseley; Amber Sealy; Diana Andreea Zbarcea; Maureen Gatherer; Ho Ming Yuen; Matt MacGregor Sharp; Roy O Weller; Johannes Attems; Colin Smith; Paul R Chiarot; Roxana O Carare
Journal:  Pharmaceuticals (Basel)       Date:  2020-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.